First US Stentrode implanted at Mount Sinai in the COMMAND study

Synchron/Stentrode BCI

Surgeons at Mount Sinai West implanted the first Stentrode in a US patient without open-brain surgery. The procedure was performed in the angiography suite and represented the first US implant in Synchron's COMMAND trial under FDA IDE approval.

• First Stentrode implanted in US patient at Mount Sinai West
• Performed in angiography suite without open-brain surgery
• First patient enrolled in COMMAND trial under FDA IDE
• FDA IDE represents first approval for permanently implanted BCI device